This site is intended for healthcare professionals

Specialty hub

Neurology (CNS) and Pain

Containing dedicated Learning Zones, guidelines, trials and news for related conditions in Neurology (CNS) and Pain.

Read time: 5 mins

Last updated: 18th Jan 2021

Welcome:

Sign in/Register

Updates in your area
of interest

Articles your peers
are looking at

Bookmarks
saved

Days to your
next event

Neurology is the branch of medicine that deals with conditions and diseases involving the central nervous system (brain and spinal cord) and the peripheral nervous systems (autonomic and somatic), including their coverings, blood vessels, and all effector tissue such as muscle.

Learning Zones

MS: learnings from the pandemic and innovations in patient care

Learning Zone Homepage

MS: learnings from the pandemic and innovations in patient care

1 mins

Anticoagulation Therapy for Stroke Prevention

Learning Zone Homepage

Anticoagulation Therapy for Stroke Prevention

1 mins

COMT inhibition in Parkinson’s Disease

Learning Zone Homepage

COMT inhibition in Parkinson’s Disease

1 mins

Spinal Muscular Atrophy

Learning Zone Homepage

Spinal Muscular Atrophy

1 mins

Neuroscience and Pain Learning Zone

Learning Zone Homepage

Neuroscience and Pain Learning Zone

1 mins

Neurology encompasses over 5000 neurological diseases and relies on insights from fields such as neuroscience. This medical speciality deals with dementia including Alzheimer’s disease, Parkinson’s disease, neuromuscular disorders including spinal muscular atrophy and pain management as a sub-speciality.

Diseases in this section

Attention Deficit Hyperactivity Disorder (ADHD)

Containing relevant Learning Zones, guidelines, trials and news.

Dementia

Containing relevant Learning Zones, guidelines, trials and news.

Depression

Containing relevant Learning Zones, guidelines, trials and news.

Epilepsy

Containing relevant Learning Zones, guidelines, trials and news.

Neuromuscular Disorders

Containing relevant Learning Zones, guidelines, trials and news.

Pain

Containing relevant Learning Zones, guidelines, trials and news.

Parkinson's Disease

Containing relevant Learning Zones, guidelines, trials and news.

Related news and insights

FDA approves Vercise Genus Deep Brain Stimulation (DBS) System for Parkinsons disease.- Boston Scientific

Boston Scientific has received FDA approval of its fourth-generation Vercise Genus Deep Brain Stimulation (DBS) System for Parkinsons disease.

1 mins

Biohaven provides an update on phase II/III trial of troriluzole as a symptomatic treatment in mild-to-moderate Alzheimer's disease.

Biohaven announced that it has completed a focused analysis of the topline co-primary and key secondary data from its Phase II/III clinical trial of troriluzole as a symptomatic treatment in mild-to-moderate Alzheimer's disease (AD).

1 min

FDA indicates phase III Marigold Study of oral ganaxolone supports filing in CDKL5 deficiency disorder.- Marinus Pharma

Marinus Pharmaceuticals announced it has received a positive response from the FDA that the efficacy and safety data resulting from the company’s pivotal Phase III Marigold Study on the use of oral ganaxolone in children and young adults with CDKL5 deficiency disorder (CDD) appear sufficient to support the filing of a New Drug Application (NDA).

1 min

See all news

Related Drugs

Pizotifen 1.5mg Tablets.

Pizotifen 1.5mg Tablets.

5 mins

Pizotifen 0.5mg Tablets

Pizotifen 0.5mg Tablets

5 mins

Levetiracetam Mylan 1000 mg film-coated tablets

Levetiracetam Mylan 1000 mg film-coated tablets

26 mins

Ajovy (fremanezumab) 225 mg Pre-filled Pen for Injection

Ajovy (fremanezumab) 225 mg Pre-filled Pen for Injection

17 mins

Zebinix 800 mg tablets

Zebinix 800 mg tablets

28 mins

Rizatriptan 5 mg Orodispersible Tablets

Rizatriptan 5 mg Orodispersible Tablets

16 mins

Pregabalin Tillomed 75 mg capsules, hard

Pregabalin Tillomed 75 mg capsules, hard

21 mins

Pregabalin Tillomed 50 mg capsules, hard

Pregabalin Tillomed 50 mg capsules, hard

21 mins

Pregabalin Tillomed 300 mg capsules, hard

Pregabalin Tillomed 300 mg capsules, hard

21 mins

Pregabalin Tillomed 25 mg capsules, hard

Pregabalin Tillomed 25 mg capsules, hard

21 mins

Pregabalin Tillomed 225 mg capsules, hard

Pregabalin Tillomed 225 mg capsules, hard

21 mins

Pregabalin Tillomed 200 mg capsules, hard

Pregabalin Tillomed 200 mg capsules, hard

21 mins

Pregabalin Tillomed 150 mg capsules, hard

Pregabalin Tillomed 150 mg capsules, hard

21 mins

Pregabalin Tillomed 100 mg capsules, hard

Pregabalin Tillomed 100 mg capsules, hard

21 mins

14 mins

Related Journals

The Association Between Vitamin D Status, Vitamin D Supplementation, Sunlight Exposure, and Parkinson's Disease: A Systematic Review and Meta-Analysis.

The Association Between Vitamin D Status, Vitamin D Supplementation, Sunlight Exposure, and Parkinson's Disease: A Systematic Review and Meta-Analysis.

1 mins

Assessing pain in non-intubated critically ill patients unable to self report: an adaptation of the Behavioral Pain Scale.

Assessing pain in non-intubated critically ill patients unable to self report: an adaptation of the Behavioral Pain Scale.

1 mins

Emergency Management of Epilepsy and Seizures.

Emergency Management of Epilepsy and Seizures.

1 mins

Alemtuzumab depletion failure can occur in multiple sclerosis.

Alemtuzumab depletion failure can occur in multiple sclerosis.

1 mins

Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.

Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.

1 mins

Neuropathology of Alzheimer's disease.

Neuropathology of Alzheimer's disease.

1 mins

Therapeutic Monoclonal Antibodies: What Headache Specialists Need to Know.

Therapeutic Monoclonal Antibodies: What Headache Specialists Need to Know.

1 mins

Association of White Matter Structure With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

Association of White Matter Structure With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

1 mins

Methylphenidate hydrochloride modified-release in adults with attention deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial.

Methylphenidate hydrochloride modified-release in adults with attention deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial.

1 mins

How do Migraines Impact Patient Day-To-Day life? An Exploratory Analysis of Patient Reported Data From The Patientslikeme Community

How do Migraines Impact Patient Day-To-Day life? An Exploratory Analysis of Patient Reported Data From The Patientslikeme Community

1 mins

Related Guidelines

Cannabis-based medicinal products

This guideline covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.

1 mins

Risk reduction and management of delirium

This guideline provides recommendations based on current evidence for best practice in the detection, assessment, treatment and follow up of adults with delirium, as well as reducing the risk of delirium.

1 min

Pharmacological management of migraine

This guideline provides recommendations on the pharmacological management of adults with acute migraine, and prophylaxis for patients with episodic or chronic migraine or medication overuse headache.

1 min

See all guidelines

Related Clinical Trials

An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis (TOWER)

An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis (TOWER)

3 mins

Identification of a Biomarker Predictive of Evolution of Parkinson Disease (GLIAPARK)

Identification of a Biomarker Predictive of Evolution of Parkinson Disease (GLIAPARK)

3 mins

Efficacy and Safety of Ofatumumab Compared to Placebo in Patients With Relapsing Multiple Sclerosis Followed by Extended Treatment With Open-label Ofatumumab

Efficacy and Safety of Ofatumumab Compared to Placebo in Patients With Relapsing Multiple Sclerosis Followed by Extended Treatment With Open-label Ofatumumab

3 mins

Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults (GWPCARE3)

Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults (GWPCARE3)

4 mins

Simvastatin in Secondary Progressive Multiple Sclerosis (MS-OPT)

Simvastatin in Secondary Progressive Multiple Sclerosis (MS-OPT)

3 mins

Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ?1 Month to <4 Years With Partial-onset Seizures

Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ?1 Month to <4 Years With Partial-onset Seizures

3 mins

Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS)

Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS)

1 mins

A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) (CLARITY)

A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) (CLARITY)

2 mins

Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine

Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine

2 mins

Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) in Relapsing Multiple Sclerosis (RMS)

Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) in Relapsing Multiple Sclerosis (RMS)

3 mins

Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063) (ENLIGHTEN)

Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063) (ENLIGHTEN)

3 mins

Impact of Bosutinib on Safety, Tolerability, Biomarkers and Clinical Outcomes in Dementia With Lewy Bodies

Impact of Bosutinib on Safety, Tolerability, Biomarkers and Clinical Outcomes in Dementia With Lewy Bodies

4 mins

Related Events

The XXV World Congress Of Neurology 2021

The XXV World Congress Of Neurology 2021

1 mins

BNA 2021 Festival Of Neuroscience

BNA 2021 Festival Of Neuroscience

1 mins

European Neurosurgery 2021

European Neurosurgery 2021

1 mins

World Congress for Brain Mapping and Therapeutics of SBMT 2021 (SBMT 2021)

World Congress for Brain Mapping and Therapeutics of SBMT 2021 (SBMT 2021)

1 mins

Your peers are looking at...

Favourable results for Elocta when evaluating treatment options for haemophilia A.- SOBI

Favourable results for Elocta when evaluating treatment options for haemophilia A.- SOBI

2 mins

Carbaglu receives FDA approval for a new indication to treat acute hyperammonemia associated with propionic acidemia and
methylmalonic acidemia.-Recordati

Carbaglu receives FDA approval for a new indication to treat acute hyperammonemia associated with propionic acidemia and methylmalonic acidemia.-Recordati

1 mins

Phase III BLAZE-1 trial of LY CoV555 and LY CoV016 meets primary endpoint in COVID-19.- Eli Lilly

Phase III BLAZE-1 trial of LY CoV555 and LY CoV016 meets primary endpoint in COVID-19.- Eli Lilly

1 mins

EU approves Keytruda for metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer.- Merck Inc

EU approves Keytruda for metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer.- Merck Inc

1 mins

Myovant Sciences and Pfizer announce positive one-year data from phase III SPIRIT extension study of once-daily relugolix combination therapy in women with endometriosis.

Myovant Sciences and Pfizer announce positive one-year data from phase III SPIRIT extension study of once-daily relugolix combination therapy in women with endometriosis.

1 mins

Phase III trial of REGEN-COV shows positive data in prevention of COVID-19.- Regeneron Pharma

Phase III trial of REGEN-COV shows positive data in prevention of COVID-19.- Regeneron Pharma

1 mins

Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response

Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response

1 mins

Serum level of soluble interleukin 6 receptor is a useful biomarker for identification of treatment-resistant major depressive disorder

Serum level of soluble interleukin 6 receptor is a useful biomarker for identification of treatment-resistant major depressive disorder

1 mins

Efficacy and safety of tipepidine as adjunctive therapy in major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial

Efficacy and safety of tipepidine as adjunctive therapy in major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial

1 mins

Benefit-Risk Assessment of Esketamine Nasal Spray vs. Placebo in Treatment-Resistant Depression

Benefit-Risk Assessment of Esketamine Nasal Spray vs. Placebo in Treatment-Resistant Depression

1 mins